Phase
Condition
Limb Spasticity
Treatment
BiCNS
Clinical Study ID
Ages 22-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Participants must meet all inclusion criteria, verified by medical evaluation, psychological evaluation, and review of medical history. Inclusion criteria include:
Participants with C4-C6 tetraplegia from any etiology except neurodegenerativedisease (e.g. amyotrophic lateral sclerosis) or active cancer.
Complete or incomplete spinal cord injury classified by the American Spinal InjuryAssociation (ASIA) as A or B or C if fewer than three muscle groups in the leg andfoot (as identified in the ASIA Impairment Scale) can be contracted
Injury more than one year prior to enrollment
Participant has a life expectancy of greater than 5 years
Meeting surgical safety criteria, including surgical clearance by the participant'sprimary healthcare provider, study physicians, and any necessary consultants
Willingness and ability to provide informed consent
Screened by rehabilitation psychologist with a result showing that the participanthas a stable psychosocial support system with caregiver capable of monitoringparticipant throughout the study
Ability and willingness to travel to up to fifty miles to study location up to threedays per week for the duration of the study
Ability to understand and comply with study session instructions
Pain well controlled without narcotic medications
No other neurological, orthopedic conditions beyond the spinal cord injury
Participant consents to the study and still wishes to participate at the time of thestudy
Exclusion
Exclusion Criteria:
All interested participants will be reviewed for the presence of exclusion criteria by medical evaluation, review of medical history, self (or assistant) report and evaluation by a psychologist. Presence of any of the following criteria will exclude participants from eligibility to participate. In addition, the medical team has the right to withdraw the participant at any time if any of the exclusion criteria emerge and participants can withdraw at any time for any reason. Withdrawal details are outlined below exclusion criteria. Exclusion criteria include:
Neurological conditions: Impaired receptive and/or expressive verbal communicationskills
Presence of memory impairment on the Rey Auditory Verbal Learning Test
Intellectual impairment: score of 26 or less on the Mini-Mental State Examination orhistory of Intelligence Quotient < 80
Chronic psychiatric illness, including psychosis and treatment-resistant majordepression, as indicated by a diagnosis of Axis I or Axis II on the SymptomChecklist-90-Revised Test
Ventilator dependent
Implanted devices such as: pacemakers, cardiac defibrillators, spinal cord or vagalnerve stimulators, deep brain stimulators, cochlear implants or any otherimplantable device incompatible with MRI.
History of drug or alcohol dependence in past 24 months
Cerebral lesions affecting frontal and parietal lobes
Medical conditions contraindicating surgery of a chronically implanted device (e.g.osteomyelitis, diabetes, hepatitis, any autoimmune disease/disorder, epilepsy, skindisorders causing excessive skin sloughing or poor wound healing, blood or cardiacdisorder requiring chronic anti-coagulation)
Other chronic, unstable medical conditions that could make control unsuitable (suchas tremor or spasticity)
Presence of pre-surgical findings in anatomical, functional, and/or vascularneuroimaging that makes achieving implant locations within desired risk levels toochallenging (to be decided by neurological and neurosurgical team)
Prior cranioplasty
Inability to undergo MRI or anticipated need for an MRI during the study period
Participants with active infections or unexplained fever
Participants with other morbid conditions making the implantation of the recordingelements unsafe; not limited to: significant pulmonary, cardiovascular, or renalimpairments making the surgical procedure unsafe
Pregnancy (confirmation through blood test)
Nursing an infant, planning to become pregnant, or not using adequate birth control
Corrected vision no worse than 20/30
HIV or AIDS infection
Existing scalp lesions or skin breakdown
Chronic oral or intravenous use of steroids or immunosuppressive therapy
Active cancer within the past year or requires chemotherapy
Uncontrolled autonomic dysreflexia within the past 3 months
An implanted ventricular shunt
Suicidal ideation within the past 12 months
Medications that affect neuroplasticity: neuroleptics, Benzodiazepines (BDZ),Tricyclic Antidepressants (TCA).
Study Design
Study Description
Connect with a study center
Department of Neurology
Baltimore, Maryland 21287
United StatesActive - Recruiting
Department of Physical Medicine and Rehabilitation
Baltimore, Maryland 21287
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.